Haleon and Tamro continue cooperation in Finland
- We are extremely pleased to continue our collaboration with Tamro by entering this new, multi-year contract. Tamro has a proven track record of delivering outstanding warehousing and distribution services and has been a reliable partner for many years. We look forward to our continued collaboration and the important role they play in supporting our purpose of delivering better everyday health with humanity says Carlos Oropeza, General Manager for Haleon.
- We’re delighted to extend our collaboration with our long-term partner. We are proud at Tamro to be able to ensure the availability throughout Finland of Haleon’s excellent and successful products, such as Panadol, Voltaren, Nicotinell, and Otrivin says Tamro’s Key Account Manager Petteri Lajolinna.
About Haleon
Haleon is a global leader in consumer health, with brands trusted by millions of consumers globally. The group employs over 22,000 people across 170 markets, who are united by Haleon’s purpose - to deliver better everyday health with humanity. Haleon’s product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.
Learn more: www.haleon.com/
Tamro Corporation
Tamro’s mission is to deliver health. We deliver almost 60 percent of all pharmaceuticals required in hospitals, pharmacies and retail stores throughout Finland. In addition to distributing pharmaceuticals and other health products, we offer data-driven services, sales and marketing services, as well as digital home care solutions. As part of the Finnish healthcare network, we have been involved in developing and improving both pharmaceutical services and the wellbeing of Finnish people since 1895.
Tamro Corporation´s turnover is 1.6 billion euros, and we currently employ 470 professionals. Our subsidiaries and joint ventures include Medaffcon Oy and Pharmac Finland Oy. Tamro is part of PHOENIX group, the leading healthcare service provider in Europe.
Learn more: www.tamro.fi/en
Contacts
Petteri LajolinnaKey Account Manager
Tel:+358 40 575 5344petteri.lajolinna@tamro.comAbout Tamro Oyj
Tamro Corporation
Tamro’s mission is to deliver health. We deliver almost 60 percent of all pharmaceuticals required in hospitals, pharmacies and retail stores throughout Finland. In addition to distributing pharmaceuticals and other health products, we offer data-driven services, sales and marketing services, as well as digital home care solutions. As part of the Finnish healthcare network, we have been involved in developing and improving both pharmaceutical services and the wellbeing of Finnish people since 1895.
Tamro Corporation´s turnover is 1.6 billion euros, and we currently employ 470 professionals. Our subsidiaries and joint ventures include Medaffcon Oy and Pharmac Finland Oy. Tamro is part of PHOENIX group, the leading healthcare service provider in Europe.
Learn more: www.tamro.fi/en
Subscribe to releases from Tamro Oyj
Subscribe to all the latest releases from Tamro Oyj by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Tamro Oyj
Haleon ja Tamro jatkavat yhteistyötään Suomessa1.3.2023 09:01:16 EET | Uutinen
Lääkeyritys Haleon ja lääkkeiden ja terveystuotteiden jakelija ja palveluntarjoaja Tamro ovat allekirjoittaneet uuden monivuotisen sopimuksen (Haleon tunnettiin nimellä GlaxoSmithKline Consumer Healthcare Finland 18.7.2022 saakka). Sopimuksen mukaan Tamro vastaa jatkossakin Haleonin tuotteiden varastoinnista ja jakelusta apteekeille, sairaaloille ja vähittäiskaupoille Suomessa.
Lahjoitamme 10 000 euron arvosta lahjakortteja perheille Hope ry:n kautta22.12.2022 10:04:12 EET | Uutinen
Joulun tullessa Tamro lahjoittaa vähävaraisille perheille yhteensä 200 lahjakorttia Tampereella ja pääkaupunkiseudulla yhteistyössä Hope ry:n kanssa. Perheiden tukeminen joulunaikaan on jo useamman vuoden jatkunut perinne.
Olo-apteekille uusi omistaja – verkkokauppaan panostaminen jatkuu8.7.2022 13:59:34 EEST | Tiedote
Olo-apteekki Oy saa uuden pääomistajan. Forssell Consulting Oy on ostanut 8.7.2022 Tamro Oyj:ltä yrityksen osakekannan. Olo-apteekin toiminta ja verkkokaupan palvelut asiakkaille jatkuvat kaupan jälkeen ennallaan.
The cooperation between Tamro and Otsuka started22.3.2022 09:55:06 EET | News
The Japanese pharmaceutical company Otsuka and service provider and distributor of pharmaceuticals and health products Tamro have started cooperating in Finland. The multi-year agreement covers the storage and distribution of pharmaceutical products to pharmacies and hospitals.
Tamro ja Otsuka aloittivat yhteistyön22.3.2022 09:37:58 EET | Uutinen
Japanilainen lääkeyritys Otsuka ja lääkkeiden sekä terveystuotteiden jakelija ja palveluntarjoaja Tamro ovat aloittaneet yhteistyön Suomessa. Monivuotinen sopimus kattaa lääkkeiden varastoinnin ja jakelun apteekeille ja sairaaloille.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom